Oklo (NYSE: OKLO) has fallen below $50 per share, extending a downward slide that began in mid-October 2025, erasing more than 70% of its value from its 52-week high.
Not long ago, investors were paying roughly four times today’s price for a nuclear energy company whose core vision has not fundamentally changed since its peak.
The sharp selloff raises a critical question for long-term investors: does the decline represent a genuine buying opportunity, or does it reflect deeper concerns about the company’s prospects?
In October 2025, just as the stock began sliding, Oklo entered a strategic partnership with European reactor developer newcleo to develop fuel fabrication and manufacturing infrastructure in the United States.
Nuclear fuel supply is widely expected to become a significant bottleneck for the energy sector, and the newcleo partnership could give Oklo greater control over that critical part of the nuclear supply chain.
At the start of 2026, Oklo announced a major commercial agreement with Meta Platforms (NASDAQ: META) to power a campus in Ohio, targeting delivery of around 1.2 gigawatts of capacity by 2030.
In March, Oklo announced that its Groves Isotopes Test Reactor, acquired through its Atomic Alchemy acquisition, had received important regulatory approvals to help the reactor reach criticality by a deadline of July 4.
The July 4 target was selected by the U.S. government, with the Department of Energy aiming to bring multiple test reactors to criticality on that date to mark the nation’s 250th anniversary.
The Groves reactor was fast-tracked under the Trump administration’s Energy Reactor Pilot Program, which accelerates approvals and regulatory timelines for nuclear systems pursuing commercial licensing.
Oklo is now targeting a self-sustaining chain reaction, known as criticality, before the end of July 2026, which would mark its first major operational milestone as a pre-revenue company.
Despite the positive developments, Oklo still faces its most pressing structural challenges, including securing full regulatory approval to commercialize its reactors and proving its technology can perform in real-world conditions.
Those hurdles could take years to resolve, and there is no guarantee the company will successfully clear them within any predictable timeframe.
Oklo’s current market capitalization sits at approximately $8 billion, a figure that remains elevated by traditional valuation standards despite the significant share price decline.
For investors willing to think on a decade-long time horizon and accept significant risk, today’s price may represent a reasonable entry point for a small, speculative position in the nuclear energy space.
